curasan AG has signed an exclusive distribution agreement with Shanghai Foshion Medical Systems Co., Ltd. The agreement will give Foshion Medical the exclusive right to distribute the granular variant of the bone regeneration substance CERASORB(R), a product which has already received approval for the Chinese dental market. Foshion Medical will also support the planned approval of other curasan dental product variants in China, such as foam and paste. The agreement guarantees Foshion Medical the exclusive distribution rights to the entire dental product portfolio in China.